Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peptide absent sequences emerging in human cancers.

European journal of cancer (Oxford, England : 1990) - 1 Jan 2024

Tsiatsianis Georgios Christos, Chan Candace S Y, Mouratidis Ioannis, Chantzi Nikol, Tsiatsiani Anna Maria, Yee Nelson S, Zaravinos Apostolos, Kantere Verena, Georgakopoulos-Soares Ilias

Abstract excerpt

Early diagnosis of cancer can significantly improve survival of cancer patients; however sensitive and highly specific biomarkers for cancer detection are currently lacking for most cancer types. Nullpeptides are short peptides that are absent from the human proteome. Here, we examined the emergence of nullpeptides during cancer development. We analyzed 3,600,964 somatic mutations across 10,064 whole exome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Mutation

Share to Neoplasms

Share to Oncogenes

Share to Peptides

Source

Identifiers

PMID: 37952501
DOI: 10.1016/j.ejca.2023.113421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peptide absent sequences emerging in human cancers.PMID 37952501Read ↗

Absent from DNA and protein: genomic characterization of nullomers and nullpeptides across functional categories and evolution.Semantic proximity Read ↗

Utilizing nullomers in cell-free RNA for early cancer detection.Semantic proximity Read ↗

Absent from DNA and protein: genomic characterization of nullomers and nullpeptides across functional categories and evolutionSemantic proximity Read ↗

neomerDB: a comprehensive database of neomer biomarkers in cancer.Semantic proximity Read ↗

CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteinsSemantic proximity Read ↗

Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.Semantic proximity Read ↗

Utilizing nullomers in cell-free RNA for early cancer detectionSemantic proximity Read ↗

Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigensSemantic proximity Read ↗

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinomaSemantic proximity Read ↗

Variable Mutation Expression in Human Cancers: A "Hide-and-Seek" Mechanism Linked to Differential MHC-I Presentation Dynamics.Semantic proximity Read ↗

Lack of detectable neoantigen depletion in the untreated cancer genomeSemantic proximity Read ↗

Revisiting neoantigen depletion signal in the untreated cancer genomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.